Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial
Titel:
Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial
Auteur:
Oliva, Esther N Alati, Caterina Santini, Valeria Poloni, Antonella Molteni, Alfredo Niscola, Pasquale Salvi, Flavia Sanpaolo, Grazia Balleari, Enrico Germing, Ulrich Fenaux, Pierre Stamatoullas, Aspasia Palumbo, Giuseppe A Salutari, Prassede Impera, Stefana Avanzini, Paolo Cortelezzi, Agostino Liberati, Anna Marina Carluccio, Paola Buccisano, Francesco Voso, Maria Teresa Mancini, Stefano Kulasekararaj, Austin Morabito, Fortunato Bocchia, Monica Cufari, Patrizia Spiriti, Maria Antonietta Aloe Santacaterina, Irene D'Errigo, Maria Grazia Bova, Irene Zini, Gina Latagliata, Roberto